FAQ/Help |
Calendar |
Search |
Today's Posts |
08-25-2016, 10:30 AM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
Forbes Stealthy Biotech Revives Stalled Parkinson's Drug, Reveals Plans In Alzheimer's and ALS Forbes Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning. It is also announcing that it has raised ... Denali snags $130 million, deals in quest to summit Alzheimer's, ALS, Parkinson'sSan Francisco Business Times (blog) Denali grabs $130M more as it heads into the clinic, reveals dealsFierceBiotech all 4 news articles » More... |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's And Alzheimer's | Parkinson's Disease |